Review: could Non-hodgkin's lymphoma cause Malabsorption?
This is a review of Malabsorption among 10,166 people who have Non-hodgkin's lymphoma. We analyze the Non-hodgkin's lymphoma patients by their gender and age, drugs used, and common conditions other than Non-hodgkin's lymphoma. The review is created by eHealthMe based on reports from FDA and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. We use data reported since 1977 till to date. All studies are personalized to gender and age. Start now >>>
Non-hodgkin's lymphoma (latest reports from 30,088 patients) is typically treated by Rituxan.
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract) (latest reports from 7,493 patients) has been reported by people with osteoporosis, high blood pressure, high blood cholesterol, crohn's disease, depression.
On Mar, 2, 2014: 10,166 people who have non-hodgkin's lymphoma are studied. Among them, 3 (0.03%) have Malabsorption.
Gender of people who have non-hodgkin's lymphoma and experienced Malabsorption * :
Age of people who have non-hodgkin's lymphoma and experienced Malabsorption * :
Severity of the symptom * :
Top co-existing conditions for these people * :
- Prophylaxis (3 people, 100.00%)
- Non-hodgkin's lymphoma (1 people, 33.33%)
Most common drugs used by these people * :
- Neupogen (3 people, 100.00%)
- Prednisone (3 people, 100.00%)
- Cyclophosphamide (3 people, 100.00%)
- Warfarin sodium (1 people, 33.33%)
- Treanda (1 people, 33.33%)
- Acyclovir (1 people, 33.33%)
- Alendronate sodium (1 people, 33.33%)
- Anastrozole (1 people, 33.33%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Non-hodgkin's lymphoma, Malabsorption
You can also:
Common treatments for Non-hodgkin's Lymphoma and their efficacy:
Could your drug cause it?
Browse all Non-hodgkin's lymphoma symptoms from A to Z:
Comments from related studies:
From this study (11 months ago):
Malabsorption is off and on, depending on diet. Began in late 1960s from a 3-year bout with
ameobic dysentery. In recent years, external xray treatment for prostate cancer has exacerbated
this condition and diarrhea.
From this study (12 months ago):
Post 2 years on rituximab for 12 doses,after completing 8 cycle of R-CHOP.
WBC and ANC remain low.
From this study (13 months ago):
Uti seems to appear within month of start-ups
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Non-hodgkin's lymphoma, Malabsorption
You may be interested at these reviews (what is this?):
- Non-hodgkin's lymphoma in lipitor
My mother is in remission from non-hodgkins lymphoma. She took lipitor prior to her illness
- I got pneumonia while taking topamax, obvious correlation
I do not take all the medicines above all the time but I am using an implanted pump giving me less than 2mg of dilaudid per day, 75 mg effexor daily and usually buspar. Dr prescribed topamax within 4 days I was hospitalized with Pneumonia, stayed a week came home a week had a clear chest x ray and ...
More reviews for: Non-hodgkin's lymphoma, Malabsorption
Related drug studies for: Non-hodgkin's lymphoma, Malabsorption
Recent Non-hodgkin's Lymphoma related drug comparison:
More related comparison studies for: Non-hodgkin's lymphoma, Malabsorption
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.